| abstract |
The invention relates, in a preferred embodiment, to medicaments having pharmacological properties unknown to date, useful in the medicinal therapy of fibrotic diseases, for the repair and prevention of fibrotic lesional tissues. Said medicaments include as active ingredient 5-methyl-1-phenyl-2- (1H) -pyridone. The composition of this invention is new as an anti-fibrotic drug, i.e., as an agent for treating fibrosis. Not all of the existing compounds have been demonstrated to prove their effectiveness in repairing and preventing fibrotic damage. |